ASHP Foundation's forecast report feels more relevant than ever this year

While the ASHP Foundation's annual pharmacy forecast is not intended to be an accurate prediction of future events, it's right on ball for 2021. “We chose focus preparing leaders a ‘black swan’ event,” said Erin Fox, PharmD, BCPS, senior director at University Utah Health. “Who knew that in 2021 we would all facing truly unprecedented year. You can argue COVID-19 wasn’t exactly event as pandemics have certainly been predicted, but it was unexpected.” reports are used by health-system pharmacists and inform their strategic planning efforts. “I am honestly surprised despite our group only seeing very early stages, so much still current,” who helped author first section report global drug supply chain. “We’ve seen intense nature chain well cyber security issues.” The full report, titled Foundation Pharmacy Forecast 2021: Strategic Planning Advice Departments Hospitals Health Systems, appeared March 15, 2021, issue AJHP. greatest control over scope enterprise workforce within enterprise, some those factors where advocate decision makers,” wrote Joseph DiPiro, FCCP, FAAAS, dean School Virginia Commonwealth University, report. broken up into seven chapters or sections authored different pharmacist experts. Each provides summary survey findings, assessment perspective chapter author, recommendations. Survey responses were included from 272 full-time pharmacists, with many holding title chief officer, pharmacy, associate/assistant pharmacy. Most respondents practice 10 years. discusses how pandemic has laid bare fragility medication Not does provide insight what health systems do prepare pandemics, also they should breaches cybersecurity could disrupt availability reduce quality medications. second dives care access topics, which especially relevant under light racial equity. Topics covered this include telehealth services, technicians role access, legal regulations concerning pharmacists’ practice, alignment formulary decisions, inpatient non-FDA–regulated therapies. In next analytics use big data, authors write: “Most focused information technology installation data storage, includes advanced clinical systems, electronic records, business intelligence, tools—the ‘things’ collect data. time come place more emphasis output these harness vast knowledge through analysis, use, dissemination data.” fourth financing delivery, variety topics presented—from benefit manager transparency contracts online distributors value-based contracts. fifth patient safety addresses leader roles therapeutics committees general. tie staff resilience well-being safety. discuss expansion primary settings potential redeployment traditional acute positions. Lastly, delves current challenges oversupply graduates, federal provider status recognition, variable requirements education credentialing technicians. DiPiro writes that: “The shared other executives resource help them understand recognize way emerging trends will affect areas systems.” Sections report▪The certainty uncertainty chain▪Access care: Positioning improvement▪Pharmacy data▪Health delivery: Leading uncertainty▪Patient safety: New frontiers pharmacists▪Scope enterprise: From volume value▪The workforce: need recalibrate demand leverage prescribing, technology, advance ▪The